415 related articles for article (PubMed ID: 8175021)
1. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
3. Influence of cellular DNA content on survival in advanced ovarian cancer.
Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
5. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
Hedley DW; Rugg CA; Ng AB; Taylor IW
Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma].
Novik VI; Gevorkian VA; Maksimov SIa
Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704
[TBL] [Abstract][Full Text] [Related]
7. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
Hedley DW; Friedlander ML; Taylor IW
Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
9. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
12. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
14. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
15. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
16. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
17. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometric analysis of DNA ploidy pattern in advanced gastric cancer and its relationship with prognosis].
Kimura H; Yonemura Y; Iwasa K; Ohyama S; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):288-92. PubMed ID: 2051980
[TBL] [Abstract][Full Text] [Related]
19. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric DNA analysis of malignant potential in colorectal cancer].
Ando Y; Tsuchiya A; Oki S; Sato H; Yoshida T; Kimijima I; Abe R
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():112-7. PubMed ID: 8678552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
